leisure time -WSS

leisure time

author：focus 2025-09-27 22:49:45 - browse：41613

Person wearing a smart watch. -- first opinion coverage from STAT — Adobe

The Apple Watch has secured a new qualification from the Food and Drug Administration that could make the smartwatch an appealing tool for medical device companies hoping to illustrate the benefits of a common heart procedure.

Last week, the Apple Watch’s Atrial Fibrillation History feature became the first digital tool qualified under the Medical Device Development Tools (MDDT) program. Released in 2022, the feature estimates a user’s A-fib burden, or how much time they spend in atrial fibrillation, which is an irregular heart rhythm that can cause shortness of breath and fatigue, and is also linked to an increased risk of stroke.

The qualification means that FDA has determined in advance that sponsors can use the feature as a secondary endpoint in clinical trials without having to do additional work. Specifically, the Apple Watch is qualified for use as a secondary endpoint in clinical trials for cardiac ablation devices, which reduce the electrical signals that cause A-fib by scarring the heart with extreme heat or cold energy. Pulsed field ablation is the latest version of the technology, using a controlled electric field to scar tissue rather than the riskier thermal energy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： How CRISPR works, explained in two minutes

focus

WSS

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

US intelligence assessment says Iran not currently developing nuclear weapons

Paxlovid rebound happens. Why and to whom are still a mystery

Sage considers ways to reduce costs following FDA rejection

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

It was time to plan for my old age. If only I could stop crying

focus

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Moonlake's readout produced a cash windfall. Risks remain

Neutralizing antibodies against HIV shows promise in children

The cancer drug shortage isn’t new — and neither are the solutions

Feed a cold, starve a fever? Here’s what science says

Hollywood unions extend contract negotiations for actors

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

Continuity nursing helped my family in our darkest PICU moments

It was time to plan for my old age. If only I could stop crying

Guidelines to prevent youth baseball injuries need more muscle

Tennessee woman gets emergency hysterectomy after doctors deny early abortion care

focus

Feed a cold, starve a fever? Here’s what science says

Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness

A fugitive mob suspect in Greece is betrayed by his passion for hometown Naples soccer champions

Tuberculosis patients need more than just free medication

UPS workers' union leader explains what's at stake as strike edges closer

Pennsylvania man bitten on the head by bear during attack in his garage

explore

focus

hotspot

entertainment